Nipocalimab (M281) 是一种全人源的重组非糖基化 IgG1 单克隆抗体。Nipocalimab 是一种人去糖基化 IgG1 抗FcRn单克隆抗体,在体内 pH 6.0 和胞外 pH 7.6 下均以皮摩尔亲和力与Fc 受体 (FcRn) 结合。
生物活性 | Nipocalimab (M281) is a fully human, recombinant, aglycosylatedIgG1monoclonal antibody. Nipocalimab is a human deglycosylatedIgG1anti-FcRn monoclonal antibody that binds with picomolar affinity toFc receptor(FcRn) at both endosomal pH 6.0 and extracellular pH 7.6[1][2]. |
Clinical Trial | |
性状 | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |